Stockscreener 앱 받기
16.04
3.79%
0.605
전일 마감가:
$15.43
열려 있는:
$15.43
하루 거래량:
354.28K
Relative Volume:
0.19
시가총액:
$1.83B
수익:
-
순이익/손실:
$-284.08M
주가수익비율:
-9.0084
EPS:
-1.78
순현금흐름:
$-234.65M
1주 성능:
+2.79%
1개월 성능:
+29.05%
6개월 성능:
+228.85%
1년 성능:
+37.23%
1일 변동 폭
$15.26
$16.05
1주일 범위
$15.26
$16.99
52주 변동 폭
$3.72
$16.99
코젠트 바이오사이언시스 Stock (COGT) Company Profile
명칭
Cogent Biosciences Inc
전화
617-945-5576
주소
275 WYMAN STREET, WALTHAM
COGT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COGT
Cogent Biosciences Inc
|
16.04 | 2.16B | 0 | -284.08M | -234.65M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.83 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
479.69 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
581.70 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
813.54 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
163.51 | 34.11B | 398.11M | -1.03B | -868.57M | -5.7032 |
코젠트 바이오사이언시스 Stock (COGT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 개시 | Raymond James | Strong Buy |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2024-12-11 | 다운그레이드 | Needham | Buy → Hold |
| 2024-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-02-08 | 개시 | Citigroup | Buy |
| 2023-12-11 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2023-12-08 | 개시 | JP Morgan | Overweight |
| 2023-04-28 | 개시 | Robert W. Baird | Outperform |
| 2023-03-27 | 재개 | H.C. Wainwright | Buy |
| 2022-12-14 | 개시 | Needham | Buy |
| 2022-06-28 | 개시 | Guggenheim | Buy |
| 2021-10-11 | 개시 | H.C. Wainwright | Buy |
| 2021-06-09 | 재개 | Jefferies | Buy |
| 2020-12-23 | 개시 | Piper Sandler | Overweight |
| 2020-10-14 | 개시 | Ladenburg Thalmann | Buy |
모두보기
코젠트 바이오사이언시스 주식(COGT)의 최신 뉴스
13 Biotech Stocks Charging Ahead With New 52-week HighsWill Near-term Catalysts Drive More Gains? - RTTNews
Relative strength of Cogent Biosciences Inc. in sector analysisInsider Selling & Free Daily Entry Point Trade Alerts - newser.com
Momentum divergence signals in Cogent Biosciences Inc. chartJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
Cogent Biosciences Soars to 52-Week High on "Breakthrough" Systemic Mastocytosis Trial Results - FinancialContent
Cogent Biosciences (NASDAQ:COGT) Reaches New 1-Year HighWhat's Next? - MarketBeat
Cogent Biosciences stock hits 52-week high at 16.49 USD - Investing.com
Will Cogent Biosciences Inc. stock outperform tech sector in 2025Weekly Earnings Recap & Verified Momentum Stock Alerts - newser.com
Volume spikes in Cogent Biosciences Inc. stock – what they meanJuly 2025 Big Picture & Smart Investment Allocation Tips - newser.com
How strong is Cogent Biosciences Inc. stock revenue growthJuly 2025 Setups & Trade Opportunity Analysis Reports - newser.com
Will Cogent Biosciences Inc. stock split attract more investorsJuly 2025 Outlook & Intraday High Probability Setup Alerts - newser.com
Sentiment analysis tools applied to Cogent Biosciences Inc.Trade Volume Report & Real-Time Buy Zone Alerts - newser.com
Cogent Biosciences, Inc. (COGT): Analyst Ratings Point To A Promising 30% Upside - DirectorsTalk Interviews
Will earnings trigger a reversal in Cogent Biosciences Inc.Dividend Hike & Stepwise Swing Trade Plans - newser.com
Visual trend scoring systems applied to Cogent Biosciences Inc.July 2025 Patterns & Fast Moving Trade Plans - newser.com
Cogent Biosciences (NASDAQ:COGT) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
Cogent Biosciences Inc. stock outlook for YEARJuly 2025 Catalysts & Weekly Setup with ROI Potential - newser.com
Cogent Biosciences (NASDAQ:COGT) Hits New 52-Week HighHere's Why - MarketBeat
Historical volatility pattern of Cogent Biosciences Inc. visualizedEarnings Risk Report & High Yield Stock Recommendations - newser.com
Is Cogent Biosciences Inc a good long term investmentEx-Dividend Date Alerts & Rapid Wealth Accumulation - earlytimes.in
Published on: 2025-10-05 05:47:04 - newser.com
When is the best time to exit Cogent Biosciences Inc.CEO Change & Daily Entry Point Alerts - newser.com
Cogent Biosciences Relocates Headquarters to BXP’s 180 CityPoint - Connect CRE
Cogent Biosciences patents new GTPase KRAS inhibitors - BioWorld MedTech
Published on: 2025-10-03 00:35:36 - newser.com
Is Cogent Biosciences Inc. building a consolidation basePortfolio Return Report & Precise Trade Entry Recommendations - newser.com
Cogent Biosciences Inc. (COGT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cogent Biosciences stock hits 52-week high at 14.55 USD By Investing.com - Investing.com Nigeria
Cogent Biosciences stock hits 52-week high at 14.55 USD - Investing.com
Platinum Investment Management Ltd. Boosts Stock Position in Cogent Biosciences, Inc. $COGT - MarketBeat
Biotech planning to seek first-ever FDA approval signs new Waltham lease - The Business Journals
Cushman & Wakefield Arranges 31,500-Square-Foot Lease for Cogent Biosciences in Greater Boston - Cushman & Wakefield
Cogent Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Applying big data sentiment scoring on Cogent Biosciences Inc.Weekly Stock Summary & AI Forecast Swing Trade Picks - newser.com
Published on: 2025-09-29 03:19:13 - newser.com
299,200 Stock Options: Cogent Biosciences Strengthens Team with 10 New Hires and Equity Incentives - Stock Titan
Published on: 2025-09-29 00:02:48 - newser.com
What analysts say about Cogent Biosciences Inc stockMomentum Stock Picks & Grow Generational Wealth With Ease - earlytimes.in
코젠트 바이오사이언시스 (COGT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.38%
1.19%
자본화:
|
볼륨(24시간):